mRNA |
isonicotinohydroxamic acid |
CTRPv2 |
pan-cancer |
AAC |
0.0063 |
0.9 |
mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
0.0051 |
0.9 |
mRNA |
BRD-K80183349 |
CTRPv2 |
pan-cancer |
AAC |
-0.0038 |
0.9 |
mRNA |
NVP-231 |
CTRPv2 |
pan-cancer |
AAC |
0.0037 |
0.9 |
mRNA |
BRD-K16130065 |
CTRPv2 |
pan-cancer |
AAC |
-0.0083 |
0.9 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.004 |
0.9 |
mRNA |
prochlorperazine |
CTRPv2 |
pan-cancer |
AAC |
-0.0041 |
0.9 |
mRNA |
GSK525762A |
CTRPv2 |
pan-cancer |
AAC |
-0.0032 |
0.9 |
mRNA |
BRD-K99584050 |
CTRPv2 |
pan-cancer |
AAC |
0.0058 |
0.9 |
mRNA |
neratinib |
CTRPv2 |
pan-cancer |
AAC |
0.0037 |
0.9 |